Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Depreciation & Amortization (CF) (2023 - 2025)

Historic Depreciation & Amortization (CF) for BrightSpring Health Services (BTSG) over the last 3 years, with Q3 2025 value amounting to $40.8 million.

  • BrightSpring Health Services' Depreciation & Amortization (CF) fell 1947.32% to $40.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $179.6 million, marking a year-over-year decrease of 1045.74%. This contributed to the annual value of $204.5 million for FY2024, which is 106.06% up from last year.
  • As of Q3 2025, BrightSpring Health Services' Depreciation & Amortization (CF) stood at $40.8 million, which was down 1947.32% from $41.8 million recorded in Q2 2025.
  • In the past 5 years, BrightSpring Health Services' Depreciation & Amortization (CF) ranged from a high of $54.9 million in Q4 2024 and a low of $40.8 million during Q3 2025
  • In the last 3 years, BrightSpring Health Services' Depreciation & Amortization (CF) had a median value of $50.2 million in 2023 and averaged $48.3 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 758.45% in 2024, then plummeted by 1947.32% in 2025.
  • BrightSpring Health Services' Depreciation & Amortization (CF) (Quarter) stood at $51.0 million in 2023, then increased by 7.58% to $54.9 million in 2024, then dropped by 25.74% to $40.8 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $40.8 million for Q3 2025, versus $41.8 million for Q2 2025 and $42.2 million for Q1 2025.